Ropivacaine plasma levels following nerve block on thoracic plane.

Ropivacaine plasma levels following nerve block on thoracic plane. - Plasma concentration of ropivacaine after nerve block on thoracic wall.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032571

Enrollment

Registered

2018-05-14

Start date

2018-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: elective surgery of breast cancer

Exclusion criteria

Exclusion criteria: 1)under 20 years old 2)Hard to communication 3)Unable to establish the informed consent 4)Hepatic dysfunction 5)Renal dysfunction 6)serum albumin under 3.0g/dl 7)Allergy to amid type local anesthetic 8)Medication of antiarrysmitic drug 9)Medication of anticoagulants/anti-plateletdrug 10)Coagulopathy PT-INR >1.5 11)Any other confition whitch treated as contraindication of peripheral nerve blck

Design outcomes

Primary

Measure	Time frame
Plasma ropivacaine concentration The timings of sampling are 2.5,5,10,15,30,45,60,90,120min after peripheral nerve block.	—

Secondary

Measure	Time frame
Clinical symptom of local anesthetic toxicity	—

Countries

Japan

Contacts

Public ContactAkihito Kakinuma

Teikyo university shcool of medicine hospital Anesthesisa

icg02177@nifty.com0339641211

Outcome results